GB0804213D0 - A method of printing or preventing pain - Google Patents

A method of printing or preventing pain

Info

Publication number
GB0804213D0
GB0804213D0 GBGB0804213.7A GB0804213A GB0804213D0 GB 0804213 D0 GB0804213 D0 GB 0804213D0 GB 0804213 A GB0804213 A GB 0804213A GB 0804213 D0 GB0804213 D0 GB 0804213D0
Authority
GB
United Kingdom
Prior art keywords
printing
preventing pain
pain
preventing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GBGB0804213.7A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novaremed Ltd
Original Assignee
NEW ERA BIOTECH Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by NEW ERA BIOTECH Ltd filed Critical NEW ERA BIOTECH Ltd
Priority to GBGB0804213.7A priority Critical patent/GB0804213D0/en
Publication of GB0804213D0 publication Critical patent/GB0804213D0/en
Priority to PL09717773T priority patent/PL2323644T3/pl
Priority to PT97177737T priority patent/PT2323644E/pt
Priority to ES09717773.7T priority patent/ES2505325T3/es
Priority to AU2009220931A priority patent/AU2009220931B2/en
Priority to US12/921,004 priority patent/US8883853B2/en
Priority to EP09717773.7A priority patent/EP2323644B1/en
Priority to PCT/IB2009/000448 priority patent/WO2009109850A2/en
Priority to JP2010549209A priority patent/JP5657394B2/ja
Priority to DK09717773.7T priority patent/DK2323644T3/da
Priority to CA2717692A priority patent/CA2717692C/en
Priority to IL207965A priority patent/IL207965A/en
Priority to US14/508,219 priority patent/US9199917B2/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/90—Carboxylic acid amides having nitrogen atoms of carboxamide groups further acylated
    • C07C233/91—Carboxylic acid amides having nitrogen atoms of carboxamide groups further acylated with carbon atoms of the carboxamide groups bound to acyclic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F3/00—Compounds containing elements of Groups 2 or 12 of the Periodic Table
    • C07F3/003—Compounds containing elements of Groups 2 or 12 of the Periodic Table without C-Metal linkages

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Polyethers (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
GBGB0804213.7A 2008-03-06 2008-03-06 A method of printing or preventing pain Pending GB0804213D0 (en)

Priority Applications (13)

Application Number Priority Date Filing Date Title
GBGB0804213.7A GB0804213D0 (en) 2008-03-06 2008-03-06 A method of printing or preventing pain
CA2717692A CA2717692C (en) 2008-03-06 2009-03-06 N-substituted benzenepropanamide or benzenepropenamide derivatives for use in the treatment of pain and inflammation
EP09717773.7A EP2323644B1 (en) 2008-03-06 2009-03-06 N-substituted benzenepropanamide or benzenepropenamide derivatives for use in the treatment of pain
PT97177737T PT2323644E (pt) 2008-03-06 2009-03-06 Derivados de benzenopropanamida ou benzenopropenamida, substituídos em n, com utilização no tratamento da dor
ES09717773.7T ES2505325T3 (es) 2008-03-06 2009-03-06 Bencenopropanamida N-sustituida o derivados de bencenopropenamida para su uso en el tratamiento del dolor
AU2009220931A AU2009220931B2 (en) 2008-03-06 2009-03-06 N-substitutedbenzenepropanamide or benzenepropenamide derivatives for use in the treatment of pain and inflammation
US12/921,004 US8883853B2 (en) 2008-03-06 2009-03-06 N-substituted benzenepropanamide or benzenepropenamide derivatives for use in the treatment of pain and inflammation
PL09717773T PL2323644T3 (pl) 2008-03-06 2009-03-06 N-podstawione benzenopropanoamidowe lub benzenopropanoamidowe pochodne do zastosowania w leczeniu bólu
PCT/IB2009/000448 WO2009109850A2 (en) 2008-03-06 2009-03-06 A method of treating or preventing pain
JP2010549209A JP5657394B2 (ja) 2008-03-06 2009-03-06 疼痛の治療又は予防方法
DK09717773.7T DK2323644T3 (da) 2008-03-06 2009-03-06 N-substituerede benzenpropanamid- eller benzenpropenamidderivater til anvendelse ved behandlingen af smerte
IL207965A IL207965A (en) 2008-03-06 2010-09-02 Compounds to treat or prevent pain
US14/508,219 US9199917B2 (en) 2008-03-06 2014-10-07 N-substituted benzenepropanamide or benzenepropenamide derivatives for use in the treatment of pain and inflammation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0804213.7A GB0804213D0 (en) 2008-03-06 2008-03-06 A method of printing or preventing pain

Publications (1)

Publication Number Publication Date
GB0804213D0 true GB0804213D0 (en) 2008-04-16

Family

ID=39327664

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0804213.7A Pending GB0804213D0 (en) 2008-03-06 2008-03-06 A method of printing or preventing pain

Country Status (12)

Country Link
US (2) US8883853B2 (enExample)
EP (1) EP2323644B1 (enExample)
JP (1) JP5657394B2 (enExample)
AU (1) AU2009220931B2 (enExample)
CA (1) CA2717692C (enExample)
DK (1) DK2323644T3 (enExample)
ES (1) ES2505325T3 (enExample)
GB (1) GB0804213D0 (enExample)
IL (1) IL207965A (enExample)
PL (1) PL2323644T3 (enExample)
PT (1) PT2323644E (enExample)
WO (1) WO2009109850A2 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7674829B2 (en) 2004-03-26 2010-03-09 Novaremed Limited Compounds for the treatment of AIDS and other viral diseases
GB0804213D0 (en) 2008-03-06 2008-04-16 New Era Biotech Ltd A method of printing or preventing pain
WO2011030205A1 (en) * 2009-09-09 2011-03-17 Novaremed Ltd. N-substituted benzenepropanamide or benzenepropenamide for use in the treatment of pain and inflammation
US8802734B2 (en) 2009-09-09 2014-08-12 Novaremed Limited Method of treating or preventing pain
GB201116335D0 (en) * 2011-09-21 2011-11-02 Novaremed Ltd A method of treating or preventing affective disorders
CN103998420B (zh) * 2011-12-08 2018-04-17 诺瓦麦有限公司 (s)2‑n(3‑o‑(丙‑2‑醇)‑1‑丙基‑4‑羟基苯)‑3‑苯基丙酰胺的分离的立体异构形式
RS63270B1 (sr) 2019-01-23 2022-06-30 Novaremed Ltd Jedinjenja za upotrebu u tretmanu ili profilaksi bola, inflamacije i/ili autoimuniteta
EP3939578A1 (en) 2020-07-13 2022-01-19 Novaremed Ltd. Compounds for treatment or prevention of an infection resulting from a coronavirus and/or a coronavirus-induced disease
WO2026037478A1 (en) 2023-08-11 2026-02-19 Novaremed AG (s,s)-(3-o-(propan-2-ol)-2-amino-prop-1-yl-4-hydroxybenzene and its analogues for the treatment of chronic pain

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2908691A (en) 1958-07-14 1959-10-13 Searle & Co Hydroxyphenalkylaminoalkylindoles and ethers corresponding thereto
GB1037655A (en) * 1964-05-20 1966-08-03 Koninklijke Pharma Fab Nv Di(aralkyl)amines
ZA732136B (en) 1972-04-12 1974-03-27 Lilly Co Eli Dopamine derivatives
JPS5236606A (en) 1975-09-12 1977-03-22 Tanabe Seiyaku Co Ltd Process for preparation of amino compounds
US4766106A (en) 1985-06-26 1988-08-23 Cetus Corporation Solubilization of proteins for pharmaceutical compositions using polymer conjugation
US4908322A (en) 1985-09-06 1990-03-13 The United States Of America As Represented By The Department Of Health And Human Services Derivatization of amines for electrochemical detection
US5696270A (en) 1989-05-23 1997-12-09 Abbott Laboratories Intermediate for making retroviral protease inhibiting compounds
IS2334B (is) 1992-09-08 2008-02-15 Vertex Pharmaceuticals Inc., (A Massachusetts Corporation) Aspartyl próteasi hemjari af nýjum flokki súlfonamíða
JP2848232B2 (ja) 1993-02-19 1999-01-20 武田薬品工業株式会社 アルデヒド誘導体
AU1463997A (en) * 1995-12-22 1997-07-17 Acea Pharmaceuticals, Inc. Subtype-selective nmda receptor ligands and the use thereof
US6017919A (en) * 1996-02-06 2000-01-25 Japan Tobacco Inc. Compounds and pharmaceutical use thereof
JP2941230B2 (ja) * 1997-05-06 1999-08-25 コナミ株式会社 画像表示処理装置，画像表示処理方法，及びコンピュータプログラムを記録した機械読取り可能な記録媒体
WO2002046176A1 (en) 2000-12-05 2002-06-13 Nippon Chemiphar Co., Ltd. Ppar (peroxisome proliferator activated receptor) activators
US7642290B2 (en) * 2002-10-03 2010-01-05 Novaremed Limited Compounds for use in the treatment of autoimmune diseases, immuno-allergical diseases and organ or tissue transplantation rejection
AU2003294441A1 (en) * 2002-11-22 2004-06-18 Bristol-Myers Squibb Company 1-aryl-2-hydroxyethyl amides as potassium channel openers
US7674829B2 (en) 2004-03-26 2010-03-09 Novaremed Limited Compounds for the treatment of AIDS and other viral diseases
DE102004039373A1 (de) * 2004-08-12 2006-02-23 Grünenthal GmbH Para-Alkyl-substituierte N-(4-Hydroxy-3-methoxy-benzyl)-zimtsäureamide und deren Verwendung zur Herstellung von Arzneimitteln
RU2309144C2 (ru) * 2005-03-25 2007-10-27 Общество С Ограниченной Ответственностью "Фарминтерпрайсез" Фенилсодержащие n-ацильные производные аминов, способ их получения, фармацевтическая композиция и их применение в качестве противовоспалительных и анальгетических средств
PL2026775T3 (pl) 2006-05-09 2015-12-31 Novaremed Ltd Zastosowanie inhibitorów kinazy tyrozynowej Syk w leczeniu komórkowych zaburzeń proliferacyjnych
KR20100087099A (ko) 2007-09-17 2010-08-03 아카데미아 시니카 플렉트란투스 암보이니쿠스 추출물에 의해 염증 및 염증-관련 질병을 치료하기 위한 조성물 및 방법
GB0804213D0 (en) 2008-03-06 2008-04-16 New Era Biotech Ltd A method of printing or preventing pain
CN101503370B (zh) 2009-03-02 2012-08-22 上海应用技术学院 一种n-环丙基-反-2-顺-6-壬二烯酸酰胺的合成方法
CN101503373B (zh) 2009-03-13 2013-07-24 山东大学 2-氨基-1-(4-硝基苯基)-1-乙醇类金属蛋白酶抑制剂及其制备方法和用途
US8802734B2 (en) 2009-09-09 2014-08-12 Novaremed Limited Method of treating or preventing pain

Also Published As

Publication number Publication date
CA2717692C (en) 2016-06-07
AU2009220931B2 (en) 2014-11-13
US9199917B2 (en) 2015-12-01
WO2009109850A2 (en) 2009-09-11
AU2009220931A1 (en) 2009-09-11
EP2323644B1 (en) 2014-04-23
PL2323644T3 (pl) 2014-10-31
JP5657394B2 (ja) 2015-01-21
IL207965A0 (en) 2010-12-30
US20110039936A1 (en) 2011-02-17
IL207965A (en) 2015-10-29
PT2323644E (pt) 2014-07-25
US8883853B2 (en) 2014-11-11
CA2717692A1 (en) 2009-09-11
DK2323644T3 (da) 2014-07-21
JP2011513377A (ja) 2011-04-28
WO2009109850A3 (en) 2009-12-10
US20150080473A1 (en) 2015-03-19
ES2505325T3 (es) 2014-10-09
EP2323644A2 (en) 2011-05-25

Similar Documents

Publication Publication Date Title
GB0911015D0 (en) Printing method
ZA201101639B (en) A crutch
IL212348A0 (en) Treatment method
GB2470067B (en) Method of printing
GB0803107D0 (en) Method
FIU20124170U1 (fi) Verkkojärjestelmä käyttäjän rekisteröinnin toteuttamiseksi
GB0822836D0 (en) Method
GB0810418D0 (en) Method
GB0804981D0 (en) Method
GB0807409D0 (en) Method
GB0804690D0 (en) Method
IL212011A0 (en) Stimulation apparatus
GB0807410D0 (en) Method
PL2318192T3 (pl) Sposób wykonywania dozownika lub jego części
EP2280832A4 (en) IMPRESSION
GB0809404D0 (en) Method
GB0718684D0 (en) Treatment method
GB0805862D0 (en) Method
GB0806186D0 (en) Method
GB0815655D0 (en) Printing method
GB0811166D0 (en) Method
GB0810116D0 (en) Method
GB0700807D0 (en) A method of printing
GB2453140B (en) A method of activating a composition
GB0819678D0 (en) A method

Legal Events

Date Code Title Description
COOA Change in applicant's name or ownership of the application

Owner name: NOVAREMED LTD.

Free format text: FORMER OWNER: NEW ERA BIOTECH LTD